CAMPFIRE: A Study of Ramucirumab (LY3009806) in Children and Young Adults With Synovial Sarcoma

Condition:   Synovial Sarcoma Interventions:   Drug: Ramucirumab;   Drug: Gemcitabine;   Drug: Docetaxel Sponsor:   Eli Lilly and Company Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials